Re-evaluating transarterial chemoembolization for the treatment of Hepatocellular Carcinoma: Consensus recommendations and review by an International Expert Panel
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Re-evaluating transarterial chemoembolization for the treatment of Hepatocellular Carcinoma: Consensus recommendations and review by an International Expert Panel
Authors
Keywords
-
Journal
LIVER INTERNATIONAL
Volume 34, Issue 2, Pages 174-183
Publisher
Wiley
Online
2013-09-06
DOI
10.1111/liv.12314
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- mRECIST and EASL responses at early time point by contrast-enhanced dynamic MRI predict survival in patients with unresectable hepatocellular carcinoma (HCC) treated by doxorubicin drug-eluting beads transarterial chemoembolization (DEB TACE)
- (2012) H. J. Prajapati et al. ANNALS OF ONCOLOGY
- Chemoembolization With Doxorubicin-Eluting Beads for Unresectable Hepatocellular Carcinoma: Five-Year Survival Analysis
- (2012) Katerina Malagari et al. CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY
- Conventional transarterial chemoembolisation in combination with sorafenib for patients with hepatocellular carcinoma: a pilot study
- (2012) Wolfgang Sieghart et al. EUROPEAN RADIOLOGY
- Interim analysis of START: Study in asia of the combination of TACE (transcatheter arterial chemoembolization) with sorafenib in patients with hepatocellular carcinoma trial
- (2012) Young-Hwa Chung et al. INTERNATIONAL JOURNAL OF CANCER
- Transarterial Chemoembolization for Hepatocellular Carcinoma over Three Decades: Current Progress and Perspective
- (2012) K. Takayasu JAPANESE JOURNAL OF CLINICAL ONCOLOGY
- Phase II study of concurrent transarterial chemoembolization and sorafenib in patients with unresectable hepatocellular carcinoma
- (2012) Joong-Won Park et al. JOURNAL OF HEPATOLOGY
- Comparative study between doxorubicin-eluting beads and conventional transarterial chemoembolization for treatment of hepatocellular carcinoma
- (2012) Myeong Jun Song et al. JOURNAL OF HEPATOLOGY
- Response rate and clinical outcome of HCC after first and repeated cTACE performed “on demand”
- (2012) E. Terzi et al. JOURNAL OF HEPATOLOGY
- Consensus recommendations and review by an International Expert Panel on Interventions in Hepatocellular Carcinoma (EPOIHCC)
- (2012) Joong-Won Park et al. LIVER INTERNATIONAL
- Intra- and inter-observer variability in measurement of target lesions: implication on response evaluation according to RECIST 1.1
- (2012) Daniela Muenzel et al. Radiology and Oncology
- Tumor response evaluation criteria for HCC (hepatocellular carcinoma) treated using TACE (transcatheter arterial chemoembolization): RECIST (response evaluation criteria in solid tumors) version 1.1 and mRECIST (modified RECIST): JIVROSG-0602
- (2012) Yozo Sato et al. UPSALA JOURNAL OF MEDICAL SCIENCES
- Comparison of tumor response by Response Evaluation Criteria in Solid Tumors (RECIST) and modified RECIST in patients treated with sorafenib for hepatocellular carcinoma
- (2011) Julien Edeline et al. CANCER
- Locoregional radiological treatment for hepatocellular carcinoma; Which, when and how?
- (2011) Judith Meza-Junco et al. CANCER TREATMENT REVIEWS
- Management of Hepatocellular Carcinoma in Japan: Consensus-Based Clinical Practice Guidelines Proposed by the Japan Society of Hepatology (JSH) 2010 Updated Version
- (2011) Masatoshi Kudo et al. DIGESTIVE DISEASES
- Phase III study of sorafenib after transarterial chemoembolisation in Japanese and Korean patients with unresectable hepatocellular carcinoma
- (2011) Masatoshi Kudo et al. EUROPEAN JOURNAL OF CANCER
- Transarterial chemoembolization in very early and early-stage hepatocellular carcinoma patients excluded from curative treatment: A prospective cohort study
- (2011) Irene Bargellini et al. EUROPEAN JOURNAL OF RADIOLOGY
- Management of hepatocellular carcinoma: An update
- (2011) Jordi Bruix et al. HEPATOLOGY
- Phase II Trial of Sorafenib Combined With Concurrent Transarterial Chemoembolization With Drug-Eluting Beads for Hepatocellular Carcinoma
- (2011) Timothy M. Pawlik et al. JOURNAL OF CLINICAL ONCOLOGY
- Severity and timing of progression predict refractoriness to transarterial chemoembolization in hepatocellular carcinoma
- (2011) Hwi Young Kim et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Superselective transarterial chemoembolization for hepatocellular carcinoma. Validation of treatment algorithm proposed by Japanese guidelines
- (2011) Kenichi Takayasu et al. JOURNAL OF HEPATOLOGY
- Which Response Criteria Best Help Predict Survival of Patients with Hepatocellular Carcinoma Following Chemoembolization? A Validation Study of Old and New Models
- (2011) Ju Hyun Shim et al. RADIOLOGY
- V-CLIP: Integrating plasma vascular endothelial growth factor into a new scoring system to stratify patients with advanced hepatocellular carcinoma for clinical trials
- (2010) Ahmed O. Kaseb et al. CANCER
- Evolving strategies for the management of intermediate-stage hepatocellular carcinoma: Available evidence and expert opinion on the use of transarterial chemoembolization
- (2010) J.-L. Raoul et al. CANCER TREATMENT REVIEWS
- Asian Pacific Association for the Study of the Liver consensus recommendations on hepatocellular carcinoma
- (2010) Masao Omata et al. Hepatology International
- Management of hepatocellular carcinoma: Report of Consensus Meeting in the 45th Annual Meeting of the Japan Society of Hepatology (2009)
- (2010) Shigeki Arii et al. HEPATOLOGY RESEARCH
- Modified RECIST (mRECIST) Assessment for Hepatocellular Carcinoma
- (2010) Riccardo Lencioni et al. SEMINARS IN LIVER DISEASE
- Evaluation of tumor response after locoregional therapies in hepatocellular carcinoma
- (2009) Alejandro Forner et al. CANCER
- Prospective Randomized Study of Doxorubicin-Eluting-Bead Embolization in the Treatment of Hepatocellular Carcinoma: Results of the PRECISION V Study
- (2009) Johannes Lammer et al. CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY
- Relationship between serum progesterone concentrations and cardiovascular disease, diabetes, and mortality in elderly Swedish men and women: An 8-Year prospective study
- (2009) Sven E. Nilsson et al. Gender Medicine
- Society of Interventional Radiology Position Statement on Chemoembolization of Hepatic Malignancies
- (2009) Daniel B. Brown et al. JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY
- Major achievements in hepatocellular carcinoma
- (2009) Jordi Bruix et al. LANCET
- Clinical impact of selective transarterial chemoembolization on hepatocellular carcinoma: A cohort study
- (2009) Rodolfo Sacco et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Increased expression of vascular endothelial growth factor in hepatocellular carcinoma after transcatheter arterial chemoembolization
- (2008) B. Wang et al. ACTA RADIOLOGICA
- Transcatheter Arterial Chemoembolization in Patients with Hepatocellular Carcinoma on the Waiting List for Orthotopic Liver Transplantation
- (2008) Esther Alba et al. AMERICAN JOURNAL OF ROENTGENOLOGY
- Review on transarterial chemoembolization in hepatocellular carcinoma: Palliative, combined, neoadjuvant, bridging, and symptomatic indications
- (2008) Thomas J. Vogl et al. EUROPEAN JOURNAL OF RADIOLOGY
- Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial
- (2008) Ann-Lii Cheng et al. LANCET ONCOLOGY
- Sorafenib in Advanced Hepatocellular Carcinoma
- (2008) Josep M. Llovet et al. NEW ENGLAND JOURNAL OF MEDICINE
- Development of evidence-based clinical guidelines for the diagnosis and treatment of hepatocellular carcinoma in Japan
- (2007) Masatoshi Makuuchi et al. HEPATOLOGY RESEARCH
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started